The BiPASS clinical study, in partnership with MTIC and Epworth, is to investigate PSMA PET prior to biopsy in order to evaluate the diagnostic performance of combined 68Ga-PSMA-11 PET in combination with MRI for the detection of prostate cancer.
Phase 3 study of darolutamide plus ADT
World first medical device implantation to restore erectile function
A global study to evaluate investigational radionuclide therapy
Administered Intraoperatively to Patients Undergoing Radical Prostatectomy
Screening for People with a Prostate
Erectile Dysfunction Adaptation of ACT for Compliance with an Erectile Rehabilitation Program
Robotics-Assisted Surgical Outcomes Registry
Genomically informed active surveillance in prostate cancer
Prostate cancer patients and treatment choices
We contribute over 60% of the advanced metastatic prostate cancer samples analysed globally.
As part of this global group we analyse genetic data from over 1800 men with prostate cancer.
Identifying different types of prostate cancer and enabling targeted treatment.
International registry for men with advanced prostate cancer.
Improving methods of diagnosis treatment for individuals with potentially lethal prostate cancer.
